Conexeu Sciences (NASDAQ: CNXU) has launched a human collagen program at its Vancouver research and development facility for regenerative aesthetics, starting with the production of its first pilot batch of human type I...
Conexeu Sciences (NASDAQ: CNXU) has initiated a preclinical development program for B.R.E.A.S.T. (BIO-REGENERATIVE ERGONOMICALLY ARCHITECTED SMART TISSUE), its recently unveiled 3D-printed bioregenerative breast matrix...